StockData
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

IDEXX LABORATORIES INC /DE

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$555.80−4.56 (-0.81%)

Close on Oct 19, 2026

Market cap
$44.08B
P/E (TTM)
39.1
Dividend yield
–

Earnings

Next report expected Nov 2, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 4, 2026Before market open–$4.27$4.07
Q1 FY2026
Ended Mar 31, 2026
May 5, 2026Before market open$1.14B$3.47$3.30
Q4 FY2025
Ended Dec 31, 2025
Feb 2, 2026Before market open$1.09B$3.08$2.92
Q3 FY2025
Ended Sep 30, 2025
Nov 3, 2025Before market open$1.11B$3.40$3.22
Q2 FY2025
Ended Jun 30, 2025
Aug 4, 2025Before market open–$3.63$3.50
Q1 FY2025
Ended Mar 31, 2025
May 1, 2025Before market open$998.00M$2.96–
Q4 FY2024
Ended Dec 31, 2024
Feb 3, 2025Before market open–$2.62$2.53
Q3 FY2024
Ended Sep 30, 2024
Oct 31, 2024Before market open$976.00M$2.80$2.79
Q2 FY2024
Ended Jun 30, 2024
Aug 6, 2024Before market open$1.00B$2.44$3.02
Q1 FY2024
Ended Mar 31, 2024
May 1, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 5, 2024Before market open–––

Company guidance

Outlook given with results on Aug 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Capital Expenditures2026$180.00MMaintained
Comparable growthnon-GAAP202613% to 15% growthRaised
Reported growthGAAP202612% to 14% growthRaised
EPSGAAP2026$14.69 to $14.94Raised
Operating Margin202632.3% to 32.5%Raised
Effective tax rate202621.1%Lowered
Net interest expense2026$35.00MRaised
Reported growth20269.1% to 10.3% growthNarrowed
CAG Diagnostics Recurring Revenue Growth Reported growth202610.1% to 11.3% growthRaised
Organic growthnon-GAAP20268.5% to 9.7% growthRaised
CAG Diagnostics Recurring Revenue Growth Organic growthnon-GAAP20269.5% to 10.7% growthRaised
Revenue2026$4.70B to $4.75BNarrowed

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Idexx Laboratories filed with the SEC